CAJ | 학술논문

目的提高肾嫌色细胞癌诊治水平.方法 1989年1月至2011年12月吉化集团公司总医院泌尿外科共收治肾癌患者216例,其中肾嫌色细胞癌9例(4.17％),均行根治性肾切除术.结合文献回顾分析9例肾嫌色细胞癌患者的临床和病理资料.结果术后病理分期pT13例,pT22例,pT3b 2例,pT1 N2M0 1例,pT2N2M0 1例.病理分级G2 6例,G33例.6例接受4～28个月(平均18个月)随访,1例死于急性心肌梗塞,5例无瘤生存.结论肾嫌色细胞癌是一种少见的具有特殊形态的肾脏肿瘤,根治性肾切除术是治疗肾嫌色细胞癌的首选方法,肾嫌色细胞癌的预后好于肾透明细胞癌.
목적 제고신혐색세포암진치수평.방법 1989년1월지2011년12월길화집단공사총의원비뇨외과공수치신암환자216례,기중신혐색세포암9례(4.17％),균행근치성신절제술.결합문헌회고분석9례신혐색세포암환자적림상화병리자료.결과 술후병리분기pT13례,pT22례,pT3b 2례,pT1 N2M0 1례,pT2N2M0 1례.병리분급G2 6례,G33례.6례접수4～28개월(평균18개월)수방,1례사우급성심기경새,5례무류생존.결론 신혐색세포암시일충소견적구유특수형태적신장종류,근치성신절제술시치료신혐색세포암적수선방법,신혐색세포암적예후호우신투명세포암.
Objective To evaluate the diagnosis and treament of renal chromphobe cell carcinoma (RCCC).Methods Nine RCCC patients who underwent radical nephretomy during January 1989 and December 2011 were retrospectively analysed.Results Pathological findings affirmed the diagnosis of RCCC.pTl was found in 3 patients,pT2 in 2,pT3b in 2,pT1N2M0 in 1,and pT2N2M0 in 1.G2 was confirmed in 6 cases,while G3 in 3.Six patients were followed up for 4 to 28 months (mean 18 months),and one died of acute myocardial infarction,5 were enjoying tumor-free lives.Conclusion RCCC is a morphologically distinctive uncommon subtype of RCC.Radical nephretomy may be the first treatment of choice of RCCC.The prognosis of RCCC could be better than that of clear cell renal carcinoma.